Clinical dermatology company Botanix Pharmaceuticals (ASX:BOT) has announced that Ascent Health, the second largest Payer organisation in the US, will cover Sofdra (sofpironium) topical gel, 12.45 per cent. …
Botanix expands US payer coverage for Sofdra with Ascent Health agreement
November 14, 2024 Australian Biotech
Latest Video
New Stories
-
Pharmacy Guild welcomes new qualification for the profession
November 21, 2024 - - Latest News -
Amgen welcomes expanded listing of biologic osteoporosis therapy
November 21, 2024 - - Latest News -
Few are better qualified to make a difference, as long as they are allowed to
November 21, 2024 - - Latest News -
Will the implementation group members take a principled stand against secrecy on behalf of the broader community?
November 20, 2024 - - Latest News -
Telix announces agreement to add FAP-targeting candidates to theranostic pipeline
November 20, 2024 - - Latest News -
GBMA says Australia can benefit from a biosimilar medicines funding windfall
November 20, 2024 - - Latest News -
Ramsay Health Care and Bupa join forces to develop our next generation of nurses
November 19, 2024 - - Other Health